How much funding has Scholar Rock raised?

Scholar Rock has raised $103.0M in total funding, most recently a Series C round.

Who are Scholar Rock's investors?

Scholar Rock's investors include ARCH Venture Partners, Invus, Fidelity Management, Polaris Partners, Timothy Springer, Redmile Group.

When was Scholar Rock founded?

Scholar Rock was founded in 2012.

Where is Scholar Rock headquartered?

Scholar Rock is headquartered in Cambridge, Massachusetts, United States.

What industry is Scholar Rock in?

Scholar Rock operates in Biotech, Healthcare.

How many employees does Scholar Rock have?

Scholar Rock has 51-200 employees.

Scholar Rock

IPO

Discovery and Development of Innovative Medicines

Public · Cambridge, United States · Founded 2012 · $103.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2012
Business Model: B2B
Website: scholarrock.com

Total Funding: $103.0M
Last Round: $47.0M Series CJan 2018
Rounds: 3
Type: Public

About

Scholar Rock is a clinical-stage biopharmaceutical company founded on pioneering science from Harvard Medical School and Boston Children's Hospital. The company focuses on selectively targeting growth factor proteins in the TGF-beta superfamily before activation, with a pipeline spanning neuromuscular disorders, cardiometabolic conditions, immuno-oncology, fibrotic diseases, and hematology. Scholar Rock has been publicly traded on NASDAQ (SRRK) since 2018.

Summary

Scholar Rock is a Biotech company based in Cambridge, United States, founded in 2012. It has raised $103.0M in total across 3 rounds, most recently a $47.0M Series C round in Jan 2018. Investors include ARCH Venture Partners, Invus and Fidelity Management.

LinkedIn X (Twitter)